title: The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation.
abstract: In girls and young women, irradiation of the ovaries can reduce the number of viable ovarian primordial follicles, which may lead to premature ovarian failure (POF) and subsequently to sterility. One strategy to minimize this late effect is to reduce the radiation dose to the ovaries. A primary means of reducing dose is to choose a radiotherapy technique that avoids irradiating nearby normal tissue; however, the relative risk of POF (RRPOF) due to the various therapeutic options has not been assessed. This study compared the predicted RRPOF after craniospinal proton radiotherapy, conventional photon radiotherapy (CRT) and intensity-modulated photon radiotherapy (IMRT). We calculated the equivalent dose delivered to the ovaries of an 11-year-old girl from therapeutic and stray radiation. We then predicted the percentage of ovarian primordial follicles killed by radiation and used this as a measure of the RRPOF; we also calculated the ratio of the relative risk of POF (RRRPOF) among the three radiotherapies. Proton radiotherapy had a lower RRPOF than either of the other two types. We also tested the sensitivity of the RRRPOF between photon and proton therapies to the anatomic position of the ovaries, i.e., proximity to the treatment field (2 ≤ RRRPOF ≤ 10). We found that CRT and IMRT have higher risks of POF than passive-scattering proton radiotherapy (PRT) does, regardless of uncertainties in the ovarian location. Overall, PRT represents a lower RRPOF over the two other modalities.
authors.affiliation: Department of Radiation Physics, Unit 1202, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. perezandujara@radonc.ucsf.edu
authors.forename: A
authors.initials: A
authors.lastname: Pérez-Andújar
authors.forename: W D
authors.initials: WD
authors.lastname: Newhauser
authors.forename: P J
authors.initials: PJ
authors.lastname: Taddei
authors.forename: A
authors.initials: A
authors.lastname: Mahajan
authors.forename: R M
authors.initials: RM
authors.lastname: Howell
mesh_terms: D002648:Child; D061888:Craniospinal Irradiation / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008527:Medulloblastoma / Q000532:radiotherapy; D010053:Ovary / Q000528:radiation effects; D016649:Primary Ovarian Insufficiency / Q000209:etiology*; D061766:Proton Therapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects; D018570:Risk Assessment